[PDF] Top 20 A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients

... MS patients both the BRB and the BICAMS. Mean scores of patients were lower compared to those of healthy subjects [5, 10] in all the cognitive measures ...typical cognitive profile in MS ... See full document

... on cognitive function in early, mildly disabled RRMS patients were addressed in the Italian multicenter, post-marketing COGIMUS (Cogni- tive Impairment in Multiple Sclerosis) study ...The ... See full document

... MS patients with cognitive ...of cognitive impair- ment in MS patients, and is as reliable as the original English ...MS patients may be one such limitation, because there is a known ... See full document

... the Brief Re- peatable Battery of Neuropsychological tests (BRB-N) [4] and the Minimal Assessment of Cognitive Function in MS (MACFIMS) ...MS patients, however, their imple- mentation ... See full document

... behavioural assessment of the dysexecutive syndrome; RMT, recognition memory test; VESPAR, verbal and spatial reasoning task; RR, relapsing-remitting; PP, primary progressive; NART, National adult reading test; ... See full document

... BICAMS: Brief international cognitive assessment for multiple sclerosis; BVMT-R: Brief visual memory test revised; CVLT-II: California verbal learning test II; DMD: ... See full document

... a brief assessment tool, they need to be interpreted in the context of a noteworthy limi- ...to cognitive deficits, as determined by the whole BRB and an additional Stroop Test for add- itional ... See full document

... MS patients. The Brief Repeatable Neuropsy- chological Battery (BRNB) [14,15], which includes the Selective Reminding Test (SRT) [auditory/verbal mem- ory], Controlled Oral Word Association ... See full document

... zilian-Portuguese Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) test battery, which included the SDMT, the California Verbal Learning Test, and ... See full document

... Methods: The BICAMS was applied to 105 MS patients and 60 age, gender and education matched healthy controls (HC). In order to test its reliability, BICAMS was re-administered in a subset of 25 patients ... See full document

... [20]. Assessment of balance by BBS test revealed significant difference between patient and con- trol groups in the present ...MS patients when measuring by ...of patients chosen in that study as ... See full document

... 1. Patients with secondary progressive multiple sclerosis (SPMS) were randomized to 300 mg of intravenous natalizumab every 4 weeks (n = 439) or to placebo (n = 448) for up to 96 ...of ... See full document

... Alemtuzumab is an efficacious treatment for active relapsing MS having been shown in robust clinical trials and against an active comparator to significantly reduce relapse rates, MRI outcomes and, at the very least, ... See full document

... postulate that the immune reaction initiates in the CNS and immune cells (including T cells/B cell) infiltrate into the CNS as a result. An unknown causative agent sets off a local inflammatory reaction, after which ... See full document

... It is also important to emphasize another major point that He et al make in their report. Namely, that one must be aware that lesion activity and pro- gression of MS disease are not limited to definition of contrast ... See full document

... of multiple sclerosis (MS) is at present not fully elucidated, although it is considered to result from the interaction of environmental and genetic susceptibility ...for multiple sclerosis ... See full document

... MS patients (five women and three men) presented with the symptoms of ...of patients are summarized in table ...the patients had a family history of MS and ... See full document

... the patients had received prior treatment with other disease-modifying agents, including interferons, glatiramer acetate, mitoxantrone, intravenous immune globulin G, and ...the patients did not survive, ... See full document

... Multiple Sclerosis (MS) is a chronic demyelinating dis- ease of the CNS with assumed autoimmune etiology that for many years have been supposed to be of potential viral ...MS patients have relapsing ... See full document

... of patients with clinically proven Huntington’s disease (HD) and/or positive genetic testing with 36–49 CAG repeats in the Huntingtin ...400 patients, and study completion is expected in January ... See full document